Ga-68 Dolacga PET Scan in HCC Under RFA

Not yet recruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Hepatocellular Carcinoma (HCC)Radiofrequency AblationPET ScanComputed TomographyDeep Learning
Interventions
DIAGNOSTIC_TEST

Ga-68 Dolacga PET scan

"Contrast Name: Nuclear Medicine Dolacga (Lyophilized product for the preparation of gallium Ga68 Dolacga injection).~Active Ingredient, Dosage, Route: NOTA-Hexa lactoside (INER038), 40 micrograms, IV injection.~PET Imaging Schedule: Before radiofrequency ablation therapy, one month after ablation therapy, and follow-up every three months thereafter."

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT06792097 - Ga-68 Dolacga PET Scan in HCC Under RFA | Biotech Hunter | Biotech Hunter